Europe Omega 3 & Structured lipids (Nutraceuticals) Market By Application (Functional food, Functional Beverages, Animal Feed, Dietary Supplements, Personal care ) and By Geography- Trends and Forecast upto 2019
- Report Code: OM 1002
- Publish Date: Upcoming
Omega 3 fatty acids refer to polyunsaturated fatty acids that constitute an essential element in the nutritional health of a person. Multiple functions in the human body are dependent on omega 3 fatty acids. Structured lipids are triacylglycerols (TAG), which enable the maintenance of body composition and are highly necessary in the daily food intake of a person. It essentially helps in maintain nitrogen balance in the body and also ensures sufficient absorption of fats from the food consumed. The nutraceuticals omega 3 & structured lipids are growing in demand in the European region, owing to the increased need of the population to prevent lifestyle and chronic disorders, such as osteoporosis and arthritis.
MMM assessment can be customized to suit the specific requirements of your company. Customize the report to the get current industry benchmarks and in-depth study with respect to the following considerations:
Product Type Assistance
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level.
- Review of the wide range of formulations of omega-3 and structured lipids
- Country-level analysis of the sub-types like Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), Alpha-Linolenic acid (ALA), Structured lipids, and other specialty fatty acids
Supply chain Analysis
- Analysis & Identification of the evolving supply chain infrastructure
- Volume and value of Import of these ingredients in the European region
- Analysis on raw material availability, pricing trends and distribution channels
Market Trends
- Locating specific target markets within the region through which maximum return on investment can be generated
- Study of the clinical benefits of the omega-3 and structured lipids, particularly their exact role in neural and cardiovascular development
- Detailed analysis of the rapidly expanding functional food market, in which these ingredients play a crucial role
Competitive Intelligence
- Arriving at a competitive benchmarking by taking into account the top industry players in the same category.
- Best practices of production which will ensure cost-effectiveness
- Production capacity of the key players along with number of manufacturing plants and its presence in different countries of Europe
- Tracking and analyzing real time developments of key players in the market such as expansions, new product launches and other strategic initiatives that help to stay dynamic in the market
- Periodic updates on the major trends impacting the market
Audience for This Report
· European Omega 3 & structured lipids (Nutraceuticals)companies
· European Omega 3 & structured lipids (Nutraceuticals) manufacturers
· European Omega 3 & structured lipids (Nutraceuticals) traders, distributors and suppliers
· Government and research organizations
· Associations and industry bodies
· Technology providers to European Omega 3 & structured lipids (Nutraceuticals) industries
1 Introduction
1.1 Introduce the Market
1.2 Objective of the study
1.3 Market Definition and Scope of the study
1.3.1 Market Definition
1.3.2 Areas covered
1.3.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Secondary sources
1.5.2 Primary Sources
1.5.3 Market estimation methodology (Top-down, bottom-up, data triangulation.)
1.5.4 Macro indicators for the study
1.6 Assumptions
1.7 List of Acronyms
2 Market Overview
3 Omega 3 & structured lipids (Nutraceuticals)-Europe, By Geographies
3.1 Omega 3 & structured lipids (Nutraceuticals)-Italy
3.1.1 Omega 3 & structured lipids (Nutraceuticals)-Italy, By MacroIndicators
3.1.1.1 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Italy
3.2 Omega 3 & structured lipids (Nutraceuticals)-France
3.2.1 Omega 3 & structured lipids (Nutraceuticals)-France, By MacroIndicators
3.2.1.1 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-France
3.3 Omega 3 & structured lipids (Nutraceuticals)-Germany
3.3.1 Omega 3 & structured lipids (Nutraceuticals)-Germany, By MacroIndicators
3.3.1.1 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Germany
3.4 Omega 3 & structured lipids (Nutraceuticals)-Europe - Switzerland
3.4.1 Omega 3 & structured lipids (Nutraceuticals)-Europe - Switzerland, By MacroIndicators
3.4.1.1 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Europe - Switzerland
3.5 Omega 3 & structured lipids (Nutraceuticals)-United Kingdom
3.5.1 Omega 3 & structured lipids (Nutraceuticals)-United Kingdom, By MacroIndicators
3.5.1.1 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-United Kingdom
3.6 Omega 3 & structured lipids (Nutraceuticals)-Europe - Russia
3.6.1 Omega 3 & structured lipids (Nutraceuticals)-Europe - Russia, By MacroIndicators
3.6.1.1 Omega 3 & structured lipids (Nutraceuticals)-Population Projection-Europe - Russia
3.7 Omega 3 & structured lipids (Nutraceuticals)-Europe - Other Geographies
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Asia-Pacific Nutraceuticals The Asia-Pacific Nutraceuticals market had been valued at $7,511.9 million in 2013, and is projected to reach $10,733 million by 2018, at a CAGR of 7.4%. Prebiotics, probiotics, amino acids, peptides & proteins, omega 3 & structured lipids, phytochemicals & plant extracts, minerals, vitamins are the types of Nutraceuticals. |
Upcoming |
|
|
North America Nutraceuticals The North America nutraceuticals market was valued at $6.2 billion in 2013, and is projected to reach $8.8 billion by 2018, at a CAGR of 7.0%. The North America nutraceuticals market comprises prebiotics, probiotics, amino acids, peptides, proteins, minerals, vitamins, fibers, and speciality carbohydrates. |
Apr 2015 |
|
|
Europe Nutraceuticals The Europe nutraceuticals market is projected to grow at a CAGR of 7.2% from 2014 to 2019. Nutraceuticals provide health and medicinal benefits such as the prevention and treatment of diseases in addition to basic nutritional value found in foodstuffs. |
Apr 2015 |
